Skip to search formSkip to main contentSkip to account menu

Indisetron

Known as: 1H-Indazole-3-Carboxamide, N-((7-Endo)-3,9-Dimethyl-3,9-Diazabicyclo(3.3.1)non-7-yl)-, N-(3,9-Dimethyl-Endo-3,9-Diazabicyclo(3.3.1)non-7-yl)-1H-Indazole-3-Carboxamide 
National Institutes of Health

Related topics

Related topics

1 relation
indisetron hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Sensitive identification and quantitation of parent forms of six synthetic cannabinoids in urine samples of human cadavers by liquid chromatography–tandem mass spectrometry
Human urine samples are easier to obtain than human blood samples due to noninvasiveness. The urine levels of synthetic… 
2017
2017
Cannabimimetic activities of cumyl carboxamide-type synthetic cannabinoids
Abstract1-Pentyl-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-PINACA) is a carboxamide-type synthetic cannabinoid… 
2017
2017
Schedules of Controlled Substances: Extension of Temporary Placement of THJ-2201, AB-PINACA and AB-CHMINACA in Schedule I of the Controlled Substances Act. Temporary order.
The Administrator of the Drug Enforcement Administration is issuing this temporary order to extend the temporary schedule I… 
2016
2016
1-Adamantylamine a simple urine marker for screening for third generation adamantyl-type synthetic cannabinoids by ultra-performance liquid chromatography tandem mass spectrometry
Background Synthetic cannabinoids (NOIDS) are novel psychotropic drugs (NPS) currently freely sold in the United Kingdom as… 
2016
2016
Schedules of Controlled Substances: Extension of Temporary Placement of PB-22, 5F-PB-22, AB-FUBINACA and ADB-PINACA in Schedule I of the Controlled Substances Act. Final order.
The Administrator of the Drug Enforcement Administration is issuing this final order to extend the temporary schedule I status of… 
2014
2014
Exploratory randomized trial to evaluate the effect of indisetron tablets for preventing chemotherapy-induced nausea and vomiting (CINV)/acute-onset diarrhea induced by IRIS/FOLFIRI: HGCSG0704.
624 Background: Indisetron is a 5-HT3 receptor antagonist that also antagonizes 5-HT4receptors. Indisetron tablets showed the non… 
2013
2013
Optimal Dose Period for Indisetron Tablets for Preventing Chemotherapy-Induced Nausea and Vomiting with Modified FOLFOX6: A Randomized Pilot Study
Background: Indisetron is a serotonin (5-hydroxytryptamine type 3) receptor antagonist that also antagonizes 5-hydroxytryptamine… 
2011
2011
The optimal dose period of indisetron tablets for preventing chemotherapy-induced nausea and vomiting (CINV) induced by mFOLFOX6: An exploratory trial HGCSG0703.
589 Background: Indisetron is a 5-HT3 receptor antagonist which shows also 5-HT4 antagonistic activity, that had approved in 2004… 
2009
2009
Receptor occupancy theory-based analysis of interindividual differences in antiemetic effects of 5-HT3 receptor antagonists
BackgroundThe aim of this study was to estimate interindividual differences in the antiemetic effects of 5-HT3 receptor… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)